Back to search

Article

Serine Proteases Profiles of Leishmania (Viannia) Braziliensis Clinical Isolates With Distinct Susceptibilities to Antimony

2021-01-20

Abstract excerpt

<title>Abstract</title> <p>Glucantime® (Sb<sup>V</sup>) is the first-line treatment against leishmaniasis in South America. Its effectiveness has been associated with modulation of the parasite detoxification system that, in turn, is related to serine proteases such as subtilisins. In this study, 12 <italic>Leishmania (Viannia) braziliensis</italic> isolates from patients that presented clinical cure (Responders...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8fc2509-d628-5ee4-967d-1573c211e8fd
DOI
10.21203/rs.3.rs-79982/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serine Proteases Profiles of Leishmania (Viannia) Braziliensis Clinical Isolates With Distinct Susceptibilities to AntimonyDOI 10.21203/rs.3.rs-79982/v2
Select a neighboring publication to make it the new centre.